Doctor profile · Federal record
Dr. Howard Ying, M.D.,PH.D.
Ophthalmology Physician (CMS: Ophthalmology) · Cambridge, MA
- NPI 1841236791
- Accepts Medicare
- MIPS 92.2 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5 JFK St Ste 302
Cambridge, MA 021384916
(617) 657-9464
fax (617) 491-0470 - Additional location
-
2464 Massachusetts Ave Ste 200
Cambridge, MA 021401646 - Mailing address
-
5 JFK St
Cambridge, MA 021384916
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- May 4, 2018
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Massachusetts #261272
- Medicaid
- MA #110128931A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841236791. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
44,744
Distinct HCPCS
10
Medicare allowed
$3,256,393
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 33,780 | 123 | $36 | |
92134 |
Imaging of retina | 3,271 | 1,126 | $42 | |
67028 |
Injection of drug into eye | 2,189 | 435 | $129 | |
J9035 |
Injection, bevacizumab, 10 mg | 1,499 | 360 | $71 | |
92014 |
Established patient complete exam of visual system | 1,221 | 862 | $130 | |
J0178 |
Injection, aflibercept, 1 mg | 844 | 95 | $868 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 520 | 26 | $232 | |
J7313 |
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | 380 | 15 | $483 | |
J7351 |
Injection, bimatoprost, intracameral implant, 1 microgram | 290 | 17 | $203 | |
92083 |
Exam of visual field with extended testing | 121 | 109 | $65 |
In context: peer comparison
Among 2 peers in Cambridge Ophthalmology Physician, average services per provider: 1,215. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$3,550
Transactions
75
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alimera Sciences, INC. | 12 | $1,537.80 | |
| Abbvie INC. | 16 | $521.73 | |
| Mallinckrodt Hospital Products INC. | 14 | $521.72 | |
| Genentech USA, INC. | 13 | $285.06 | |
| Sandoz INC. | 7 | $230.69 | |
| Astellas Pharma US INC | 4 | $178.95 | |
| Regeneron Healthcare Solutions, INC. | 3 | $98.07 | |
| Tarsus Pharmaceuticals, INC. | 2 | $73.75 | |
| Coherus Biosciences INC. | 1 | $40.23 | |
| Ani Pharmaceuticals, INC. | 1 | $24.13 | |
| Dompe US, INC. | 1 | $19.34 | |
| Amgen INC. | 1 | $18.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,102
Patients
890
Total drug cost
$214,620
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 423 | 142 | $8,622 |
| Prednisolone Acetate | Generic | 371 | 206 | $17,819 |
| Ketorolac Tromethamine | Generic | 207 | 76 | $3,617 |
| Brimonidine Tartrate | Generic | 183 | 64 | $5,006 |
| Timolol Maleate | Generic | 144 | 42 | $6,023 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 139 | 51 | $4,150 |
| Atropine Sulfate | Generic | 99 | 72 | $4,475 |
| Moxifloxacin (Moxifloxacin Hcl) | Brand | 83 | 56 | $2,033 |
| Ofloxacin | Generic | 80 | 72 | $1,117 |
| Dorzolamide Hcl | Generic | 77 | 26 | $2,141 |
Frequently asked questions
What is Dr. Howard Ying's medical specialty?
Dr. Howard Ying practices Ophthalmology Physician in Cambridge, MA.
Where does Dr. Howard Ying practice?
Dr. Howard Ying practices at 5 JFK St Ste 302, Cambridge, MA 021384916. Office phone: 6176579464.
What is Dr. Howard Ying's NPI?
Dr. Howard Ying's National Provider Identifier (NPI) is 1841236791, issued by NPPES.
Does Dr. Howard Ying accept Medicare assignment?
Yes. Dr. Howard Ying accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Howard Ying commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection of drug into eye (HCPCS 67028). Source: CMS Medicare Physician & Other Practitioners file.